Market Tracker

10/30 9:42am ET

Halozyme Therapeutics Inc (NASDAQ:HALO)

9.33
Real-Time Quote
 +0.02 / +0.21%
Today’s Change
6.88
Today|||52-Week Range
18.18
-37.76%
Year-to-Date

Today’s Trading

Previous close9.31
Today’s openn.a.
Day’s range-- - --
Volume43,511
Average volume (3 months)1,254,391
Market cap$1.2B
Dividend yield--
Data as of 10/29/2014

Growth & Valuation

Earnings growth (last year)-54.17%
Earnings growth (this year)+13.68%
Earnings growth (next 5 years)--
Revenue growth (last year)+29.47%
P/E ratioNM
Price/Sales30.86
Price/Book--

Competitors

 Today’s
change
Today’s
% change
BLUEbluebird bio Inc0.000.00%
NVAXNovavax Inc+0.28+5.18%
OPHTOphthotech Corp0.000.00%
AEGRAegerion Pharmaceuti...+0.17+0.52%
Data as of 9:42am ET, 10/30/2014

Financials

Next reporting dateNovember 7, 2014
EPS forecast (this quarter)-$0.15
Annual revenue (last year)$54.8M
Annual profit (last year)-$83.5M
Net profit margin-152.33%

Profile

Sector
Health Technology
Industry
Biotechnology
No executives to display
Corporate headquarters
--, --

Forecasts